Clinical Trial Update: The BENEFICIAL Study: Evaluating the Efficacy and Safety of Alagebrium (ALT-711) in Patients With Chronic Heart Failure [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of Alagebrium (ALT-711) in patients with chronic heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Alagebrium (alagebrium)

Snippet

Sponsor: Synvista Therapeutics, Inc | Conditions: Heart Failure | Phase 2 | Status: COMPLETED